On Tuesday, Dr Reddy’s Laboratories Ltd along with its subsidiaries announced the launch of an authorised generic version of NitroDur (nitroglycerin) Transdermal Infusion System in the US market. NitroDur is a trademark of USpharma Ltd.

The shares of Zee Entertainment Enterprises Limited (ZEEL) slipped more than eight per cent on Monday after the company recently announced that it has invested Rs 522 crore in its tech subsidiary, Margo Networks Private Limited.

On the capex front, the company has incurred the highest-ever capital expenditure in FY20, amounting to Rs 230 crore. Also, more than 10 new products have been developed for aero space, navy and energy sectors.

As part of its ongoing initiatives towards COVID-19 relief efforts, Hero MotoCorp, world’s largest manufacturer of motorcycles and scooters, is donating 60 first-responder mobile ambulances to authorities.

Tata Communications Limited has announced that the company will consider fundraising in its board meeting scheduled on April 15, 2020.

A leading private dairy in South India and a subsidiary of Godrej Agrovet Limited-Creamline Dairy Products Limited (CDPL) announced that it is delivering essential items like dairy products under their ‘Jersey’ portfolio in housing societies amid nationwide lockdown.

Biocon Limited and Mylan NV together have launched Fulphila, a biosimilar of Neulasta (pegfilgrastim) in Australia. Fulphila is now available on the pharmaceutical benefits scheme (PBS).

The company has received decent interest from various quarters regarding the above-mentioned product range, which includes several government agencies and foreign buyers.

The volatility index is inversely related to the equity market. India NSE Volatility Index has recently cooled off from its recent peak. Does this mean that the equity market's bottom is behind us?

Lasa Supergenerics has received an approval from Food & Drug Administration authorities to manufacture Progesterone. Soon after this development, the stock of the company gained by 4.86 per cent.